AB
XBIT icon

Amalgamated Bank’s XBiotech XBIT Stock Holding History

Amalgamated Bank’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-640
Closed -$2K – 3161
2025
Q1 		$2K Hold
640
– – ﹤0.01% 2884
2024
Q4 		$3K Hold
640
– – ﹤0.01% 2886
2024
Q3 		$5K Hold
640
– – ﹤0.01% 2788
2024
Q2 		$3K Buy
+640
New +$4.94K ﹤0.01% 2940
2022
Q2 		– Sell
-1,842
Closed -$16K – 3218
2022
Q1 		$16K Buy
+1,842
New +$18.5K ﹤0.01% 2864

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Bank's XBIT Position: Q2 2025 in Review

Amalgamated Bank sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 640 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in XBIT in Q1 2022 and held it in 5 quarters. The position peaked at $16K in Q1 2022. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Amalgamated Bank reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 640 XBiotech shares in Q2 2025, an estimated $2K.
  • Amalgamated Bank first reported a position in XBiotech in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's XBiotech position peaked at $16K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.